Symmons D P, Kendall M J, Rees J A, Hind I D
Int J Clin Pharmacol Ther Toxicol. 1983 Jul;21(7):350-4.
Ten subjects participated in a four-way, open, crossover study to investigate the effect of frusemide, flurbiprofen, flurbiprofen plus frusemide, and placebo on urinary volume, sodium, and potassium. Compared with placebo, flurbiprofen was shown to significantly reduce all three parameters. The diuretic effect of frusemide was reduced by the addition of flurbiprofen but not to a statistically significant degree. The reduction was less than in previous reports using indomethacin. As flurbiprofen is a more potent inhibitor of prostaglandin synthesis than indomethacin, these data cast doubt on the theory that nonsteroidal anti-inflammatory drugs antagonize the action of diuretics by prostaglandin synthetase inhibition. The methods for assaying the two drugs are described. A pharmacokinetic explanation of the reduction of the diuretic effects of frusemide by flurbiprofen was sought but not found.
十名受试者参与了一项四向、开放、交叉研究,以调查速尿、氟比洛芬、氟比洛芬加 速尿和安慰剂对尿量、钠和钾的影响。与安慰剂相比,氟比洛芬可显著降低所有这三个参数。 加入氟比洛芬后,速尿的利尿作用有所降低,但未达到统计学显著程度。这种降低程度小于先前 使用消炎痛的报告。由于氟比洛芬是比消炎痛更强效的前列腺素合成抑制剂,这些数据对非甾体 抗炎药通过抑制前列腺素合成酶拮抗利尿剂作用的理论提出了质疑。描述了两种药物的测定方法。 试图寻找但未找到关于氟比洛芬降低速尿利尿作用的药代动力学解释。